Search

Your search keyword '"Di Ianni, Mauro"' showing total 439 results

Search Constraints

Start Over You searched for: Author "Di Ianni, Mauro" Remove constraint Author: "Di Ianni, Mauro"
439 results on '"Di Ianni, Mauro"'

Search Results

1. A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect

2. Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial

3. Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

6. Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses

8. Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

9. Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.

10. Myelofibrosis and allogeneic transplantation: critical points and challenges.

11. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization

13. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models

14. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

15. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.

16. Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation

19. Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation.

20. Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis

21. Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia

22. Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia

23. Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma

24. Clinical-Grade–Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell–Dependent Graft-versus-Leukemia Effect in Murine Models

26. Figure S10 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

27. CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy

29. Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

30. Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)

31. Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

34. T regulatory cell separation for clinical application

35. Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines.

36. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

38. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity

39. CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice

44. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications

45. NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status

46. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35

49. Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.

50. DONOR Lymphocyte Infusions after Haploidentical STEM Cell Transplantation with Ptcy: A Study on Behalf of the Ctiwp of the EBMT

Catalog

Books, media, physical & digital resources